SLC30A9 is a gene that helps move zinc inside cells, which supports normal cell function, especially in the brain and kidneys. If it does not work properly, zinc balance can be disrupted and, in rare cases, this can cause an inherited condition with developmental delays, movement or muscle problems, and kidney involvement. The protein made by this gene helps your cells keep important internal systems working in balance. SLC30A9 is not a gene that has become widely known in popular culture.
What is a gene?
A gene is a stretch of DNA that holds instructions your cells use to make molecules or to regulate processes in the body. Some genes provide the directions for producing proteins, the parts of cells that do the work. Others mainly help determine when certain processes happen, where they happen, and how active they are. Taken together, genes affect how the body grows and works, and they can influence how you respond to food, stress, and medications. For a deeper look at this topic, you can read more in the LearnHub.
Overview
SLC30A9Gene function
What if the gene works
The SLC30A9 gene helps move zinc inside cells. This supports zinc balance and helps cell parts such as mitochondria and the endoplasmic reticulum work normally.
Risk
What if the gene does not work
More disruptive variants in the SLC30A9 gene can cause a rare condition with developmental delay, movement problems, trouble moving the eyes, and kidney disease. Milder variants may affect how early features appear and how severe they become.
Treatment
What does that mean for your treatment
No SLC30A9-specific treatment or drug selection approach is currently established for people with a pathogenic or loss-of-function variant in the SLC30A9 gene. Management is based on a person's symptoms and supportive care, while the SLC30A9 gene is mainly being studied for its role in zinc handling and cell stress rather than as a current treatment target.
Conditions associated with SLC30A9
Gene function
What if the gene works
At its core, what the SLC30A9 gene does in the body is help cells manage zinc, a mineral they need for many daily tasks. The protein made from this gene moves zinc within cells and helps keep levels steady. That balance supports normal cell function, including everyday energy use.
The SLC30A9 gene makes a transporter protein that shifts zinc to the places where cells need it. This helps zinc reach the right parts of the cell for normal daily work.
Its protein helps keep zinc levels balanced inside cells. This matters because many cell proteins need the right amount of zinc to work smoothly.
Inside the energy-making parts of cells, this gene helps manage zinc in a controlled way. That supports steady cell activity and routine energy production.
What is a variant?
A genetic variant is a minor change in the DNA sequence within a gene. These changes are common and help explain normal differences between people, including differences in appearance, metabolism, or the way the body responds to environmental influences. Many variants have no noticeable effect and are simply part of natural genetic diversity. Sometimes, though, a variant changes how a gene works more significantly and can contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Changes in the SLC30A9 gene can alter how the ZnT9 protein folds, stays stable, or reaches the right parts of the cell. Some variants partly reduce zinc transport, while more severe variants can leave little or no working protein and disturb zinc balance inside mitochondria (parts of the cell that make energy). This shows how SLC30A9 gene variants affect protein function and can help explain earlier or broader disease features.
How variants are linked to conditions
Among variants in the SLC30A9 gene linked to conditions, the clearest association is Birk-Landau-Perez syndrome, a rare inherited condition that can affect development, learning, balance, movement, and sometimes the kidneys. In affected people, pathogenic variants in both copies of the SLC30A9 gene confirm the diagnosis.
A variant is not necessarily a diagnosis
Variants in genes are a common and normal part of human biology across the general population. Most have no direct impact on health and simply reflect natural human diversity. For many genes, carrying a variant connected with a condition suggests a possible association rather than a confirmed diagnosis, especially when several genes and environmental factors play a role. In some cases, though, one well-characterized variant in a specific gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For SLC30A9, risk is mainly determined by the genetic changes a person is born with, especially when both copies of the gene are affected. There is not broadly confirmed evidence that lifestyle, diet, or everyday exposures meaningfully change the chance of developing an SLC30A9-related condition. Families may still benefit from medical follow-up to watch for symptoms early and help prevent complications.
Inheritance of SLC30A9 variants
SLC30A9-related conditions are inherited in an autosomal recessive pattern, which means a person usually needs to inherit 2 disease-causing variants in the SLC30A9 gene, 1 from each parent. Parents who each carry 1 variant are typically called carriers and usually have a 25% chance in each pregnancy of having an affected child, a 50% chance of having a child who is also a carrier, and a 25% chance of having a child who inherits neither variant. This is the main answer to how SLC30A9 gene variants are inherited within families.
What does my SLC30A9 result mean for my family?
For families with a disease-causing SLC30A9 result linked to the known SLC30A9-related condition, the pattern is recessive, which means parents are often healthy carriers. Brothers and sisters may also be carriers, and in some families a sibling may also be affected. Other relatives may want to learn whether they carry the family variant, especially if they are planning children.
Genetic information
Genetic testing
How you find out about variants
To find changes in the SLC30A9 gene, genetic testing usually uses a blood sample or saliva sample. In genetic testing for SLC30A9 variants, a lab reads the DNA sequence and compares it with the usual gene sequence to identify variants that may help explain a person’s results.
When should I consider getting a genetic test?
Genetic testing for the SLC30A9 gene may be considered when a child has a rare combination of early developmental delay, low muscle tone or movement problems, and kidney disease, especially if similar problems run in the family. It can help confirm whether SLC30A9 is the cause.
A genetic result is only one part of your health story
A genetic finding can provide useful insight, but how much it reveals depends on the condition and on the kind of variant involved. Many factors, including lifestyle, environment, age, and medical history, influence how the body functions over time. For some conditions, especially those shaped by many genes, genetic information offers context rather than certainty and is most useful when considered alongside other parts of care. In other situations, a genetic result can give a clear answer. In areas like medication response, genetic results can help place a person’s experiences in context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. This helps explain why the same medication may work well for one person, have less effect in another, or cause more side effects in someone else. Part of the difference comes from how the body absorbs, breaks down, transports, or responds to a drug, and inherited DNA changes can influence each of these steps. These differences are common and can shape both how effective a treatment is and how sensitive a person is to it.
What is Pharmacogenetics?
Pharmacogenetics examines how differences in a person’s genes can affect their response to medicines. It studies gene-drug patterns to help explain why the same treatment may work differently in different people. For many medicines, genes influence how strongly a drug works or how the body handles it. This information can support treatment choices that are more informed and tailored to the individual. To explore this subject in more detail, more information is available in the LearnHub.
Drugs influenced by the SLC30A9 gene
When should I seek medical advice?
There is not yet broad, confirmed evidence that this gene should be used to guide routine medication decisions. If you have questions about side effects, new symptoms after starting a medicine, or how your treatments fit together, talk with your doctor.
History
The SLC30A9 gene entered the medical literature in the early 2000s as researchers were cataloging genes in a larger family involved in moving zinc inside cells. Initially understood only through visible traits, later recognized as tied to a specific gene, its importance became clearer as laboratory studies and family studies progressed. From these first observations, research expanded steadily. Later, reports of families with inherited developmental and kidney related features linked variants in the SLC30A9 gene to a rare genetic condition, giving the gene a clearer place in clinical genetics. Over time, descriptions became more precise as sequencing technology improved and helped connect gene changes with patterns seen across generations.